Viewing StudyNCT00003681



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003681
Status: UNKNOWN
Last Update Posted: 2009-05-12
First Post: 1999-11-01

Brief Title: Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Anemia
Keywords:
Name View
anemia View
refractory anemia View
refractory anemia with ringed sideroblasts View
refractory anemia with excess blasts View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View
secondary myelodysplastic syndromes View